Frazier Life Sciences VIII, L.P. 3/A
3/A · Arcutis Biotherapeutics, Inc. · Filed Jan 31, 2020
Insider Transaction Report
Form 3/AAmended
Frazier Life Sciences VIII, L.P.
10% Owner
Holdings
- 509,032
Common Stock
Series A Preferred Stock
Exercise: $0.00→ Common Stock (6,360,272 underlying)Series B Preferred Stock
Exercise: $0.00→ Common Stock (2,099,019 underlying)Series C Preferred Stock
Exercise: $0.00→ Common Stock (1,074,467 underlying)
Footnotes (2)
- [F1]The reportable securities are held directly by Frazier Life Sciences VIII, L.P. ("FLS LP"). FHM Life Sciences VIII, L.P. ("FHM LP") is the general partner of FLS LP. FHM Life Sciences VIII, L.L.C. ("FHM LLC") is the general partner of FHM LP. James Topper and Patrick Heron are the sole managing members of FHM LLC. Mr. Topper, FHM LP and FHM LLC disclaims beneficial ownership of the securities held by FLS LP except, to the extent of his or its pecuniary interest therein, if any.
- [F2]Each share of the Issuer's Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock will automatically convert into 1 share of the issuer's Common Stock immediately upon the closing of the Issuer's initial public offering and has no expiration date.